Efficacy of Gemtuzumab Ozogamicin (GO) Monotherapy on Relapsed/Refractory Acute Promyelocytic Leukemia (APL)

被引：0

作者：

Takeshita, Akihiro ^{[1
]}

Ono, Takaaki ^{[1
]}

Kojima, Yumi ^{[2
]}

Kyo, Taiichi ^{[3
]}

Asou, Norio ^{[4
]}

Suzushima, Hitoshi ^{[5
]}

Yagasaki, Fumiharu ^{[6
]}

Maeda, Tomoya ^{[7
]}

Okada, Masaya ^{[8
]}

Nakaseko, Chiaki ^{[9
]}

Kanbayashi, Hiroyuki ^{[10
]}

Yamaguchi, Masaki ^{[11
]}

Kurosawa, Mitsutoshi ^{[12
]}

Tsuboi, Kosuke ^{[13
]}

Yujiri, Toshiaki ^{[14
]}

Nannya, Yasuhito ^{[15
]}

Uike, Naokuni ^{[16
]}

Akiyama, Nobu ^{[17
]}

Fukuda, Tetsuya ^{[18
]}

Karimata, Kaori ^{[19
]}

Okumura, Hirokazu ^{[20
]}

Eto, Tetsuya ^{[21
]}

Izumiyama, Koh ^{[22
]}

Watanabe, Akihiro ^{[23
]}

Aotsuka, Nobuyuki ^{[24
]}

Ito, Katsuro ^{[25
]}

Ozaki, Keiji ^{[26
]}

Naoe, Tomoki ^{[27
]}

机构：

[1] Hamamatsu Univ Sch Med, Hamamatsu, Shizuoka 4313192, Japan

[2] Ekisaikai Hosp, Nagoya, Aichi, Japan

[3] Hiroshima Red Cross Hosp, Hiroshima, Japan

[4] Kumamoto Univ, Kumamoto, Japan

[5] NTT W Kyushu Hsp, Kumamoto, Japan

[6] Saitama Med Univ, Kawagoe, Saitama, Japan

[7] Saitama Med Univ, Int Med Ctr, Hidaka, Japan

[8] Hyogo Coll Med, Nishinomiya, Hyogo 6638501, Japan

[9] Chiba Univ Hosp, Dept Hematol, Chiba, Japan

[10] Ohta Nishikouchi Hosp, Koriyama, Japan

[11] Ishikawa Prefectural Cent Hosp, Kanazawa, Ishikawa, Japan

[12] Hokkaido Cooperat Hematol Grp, Sapporo, Hokkaido, Japan

[13] Tokai Univ, Sch Med, Isehara, Kanagawa 25911, Japan

[14] Yamaguchi Univ, Sch Med, Dept Int Med 3, Ube, Yamaguchi 755, Japan

[15] Univ Tokyo, Tokyo, Japan

[16] Natl Hosp Org, Kyushu Canc Ctr, Fukuoka, Japan

[17] Teikyo Univ, Sch Med, Tokyo 173, Japan

[18] Tokyo Med & Dent Univ, Tokyo, Japan

[19] Heart Life Hosp, Nakagakigun, Japan

[20] Toyama Prefectural Cent Hosp, Toyama, Japan

[21] Hamanomachi Hosp, Dept Hematol, Fukuoka, Japan

[22] Hokkaido PWFAC Obihiro Kosei Gen Hosp, Obihiro, Hokkaido, Japan

[23] Niigata Canc Ctr Hosp, Niigata, Japan

[24] Narita Red Cross Hosp, Narita, Japan

[25] Ogawa Red Cross Hosp, Ogawa, Japan

[26] Tokushima Red Cross Hosp, Komatsushima, Japan

[27] Nagoya Univ, Grad Sch Med, Dept Hematol & Oncol, Nagoya, Aichi 4648601, Japan

来源：

BLOOD | 2011年 / 118卷 / 21期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：665 / 666

页数：2

共 50 条

[41] Gemtuzumab-ozogamicin for Bridging to Transplant in Refractory/relapsed CD33 Positive Acute Leukemia - is it Worthwhile?
Stadler, Michael
Oberstaedt, Vanessa
Dammann, Elke
Hambach, Lothar
Weissinger, Eva M.
Lueck, Catherina
Beutel, Gernot
Eder, Matthias
Ganser, Arnold
BONE MARROW TRANSPLANTATION, 2020, 55 (SUPPL 1) : 206 - 207
[42] Treatment of relapsed or refractory acute promyelocytic leukemia
Tallman, Martin S.
BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2007, 20 (01) : 57 - 65
[43] Pharmacokinetics of gemtuzumab ozogamicin as a single-agent treatment of pediatric patients with refractory or relapsed acute myeloid leukemia
Buckwalter, M
Dowell, JA
Korth-Bradley, J
Gorovits, B
Mayer, PR
JOURNAL OF CLINICAL PHARMACOLOGY, 2004, 44 (08): : 873 - 880
[44] Cytoreduction with gemtuzumab ozogamicin and cytarabine prior to allogeneic stem cell transplant for relapsed/refractory acute myeloid leukemia
Wang, Eunice S.
Zeidan, Amer
Tan, Wei
Wilding, Gregory E.
Ford, Laurie Ann
Wallace, Paul K.
Hahn, Theresa E.
Battiwalla, Minoo
McCarthy, Philip L.
Wetzler, Meir
LEUKEMIA & LYMPHOMA, 2012, 53 (10) : 2085 - 2088
[45] Gemtuzumab ozogamicin in acute myeloid leukemia
Godwin, C. D.
Gale, R. P.
Walter, R. B.
LEUKEMIA, 2017, 31 (09) : 1855 - 1868
[46] Gemtuzumab ozogamicin for acute myeloid leukemia
Appelbaum, Frederick R.
Bernstein, Irwin D.
BLOOD, 2017, 130 (22) : 2373 - 2376
[47] Safety and efficacy of gemtuzumab ozogamicin and venetoclax in patients with relapsed or refractory CD33+acute myeloid leukemia: A phase Ib study.
Arain, Saad
Christian, Sonia
Patel, Pritesh Rajni
Sweiss, Karen
Parkin, Brian
Calip, Gregory Sampang
Quigley, John G.
JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
[48] Gemtuzumab ozogamicin (GO) as monotherapy and in combination with hypomethylation agents in the treatment of acute myeloid leukemia: a systematic meta-analysis
Li, Jun
Yin, Xiaoping
HEMATOLOGY, 2022, 27 (01) : 300 - 309
[49] Gemtuzumab ozogamicin in acute myeloid leukemia
C D Godwin
R P Gale
R B Walter
Leukemia, 2017, 31 : 1855 - 1868
[50] Inotuzumab Ozogamicin Salvage Monotherapy for the Treatment of Relapsed/Refractory Acute B-Cell Lymphoblastic Leukemia
Darcin, Tahir
Yigenoglu, Tugce Nur
Sahin, Derya
Bakirtas, Mehmet
Basci, Semih
Merdin, Alparslan
Yildiz, Jale
Ulu, Bahar Uncu
Tetik, Aysegul
Iskender, Dicle
Cakar, Merih Kizil
Dal, Mehmet Sinan
Altuntas, Fevzi
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 : S192 - S193

← 1 2 3 4 5 →